Category
Bortezomib
CAS Number
886979-78-8
Molecular Formula
C19H24N4O4
Molecular Weight
372.4 g/mol
Synonym

N-[(2S)-1-[[(1R)-1-hydroperoxy-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; (R)-Hydroperoxy Des(boric Acid) Bortezomib; N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; Bortezomib Related compound L;2-Pyrazinecarboxamide, N-[(1S)-2-[[(1R)-1-hydroperoxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl];N-[(1S)-2-[[(1R)-1-Hydroperoxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide

Keywords
Aromatics
Amines
Impurities
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib R-hydroperoxide is an oxidative derivative of Bortezomib in which the hydroperoxide group forms at a specific chiral center with the R configuration. This compound arises as a degradation product during storage or handling. It is considered an impurity, and its presence is monitored to ensure it does not compromise the drug’s stability, potency, or safety.